ATE536169T1 - Zusammensetzungen enthaltend cyclopentanderivate und deren verwendung zur förderung der abschuppung der haut - Google Patents

Zusammensetzungen enthaltend cyclopentanderivate und deren verwendung zur förderung der abschuppung der haut

Info

Publication number
ATE536169T1
ATE536169T1 AT03290080T AT03290080T ATE536169T1 AT E536169 T1 ATE536169 T1 AT E536169T1 AT 03290080 T AT03290080 T AT 03290080T AT 03290080 T AT03290080 T AT 03290080T AT E536169 T1 ATE536169 T1 AT E536169T1
Authority
AT
Austria
Prior art keywords
cyclopentan
deflation
derivatives
compositions containing
coor
Prior art date
Application number
AT03290080T
Other languages
English (en)
Inventor
Jean-Luc Leveque
Maria Dalko
Christophe Boulle
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE536169T1 publication Critical patent/ATE536169T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03290080T 2002-02-04 2003-01-13 Zusammensetzungen enthaltend cyclopentanderivate und deren verwendung zur förderung der abschuppung der haut ATE536169T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0201280A FR2835526B1 (fr) 2002-02-04 2002-02-04 Nouveaux composes, compositions les comprenant et leur utilisation pour favoriser la desquamation

Publications (1)

Publication Number Publication Date
ATE536169T1 true ATE536169T1 (de) 2011-12-15

Family

ID=8871454

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03290080T ATE536169T1 (de) 2002-02-04 2003-01-13 Zusammensetzungen enthaltend cyclopentanderivate und deren verwendung zur förderung der abschuppung der haut

Country Status (5)

Country Link
EP (1) EP1333022B1 (de)
JP (1) JP3807735B2 (de)
AT (1) ATE536169T1 (de)
ES (1) ES2375954T3 (de)
FR (1) FR2835526B1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040185075A1 (en) 2003-01-31 2004-09-23 Maria Dalko Use of at least one (dihydro)jasmonic acid derivative for treating dry skin
FR2850571B1 (fr) * 2003-01-31 2006-07-07 Oreal Utilisation d'un derive d'acide(dihydro) jasmonique pour le traitement des peaux seches
FR2858320B1 (fr) 2003-07-28 2005-09-02 Oreal Utilisation d'un derive d'acide (dihydro)jasmonique comme agent desquamant.
US7365097B2 (en) 2003-07-28 2008-04-29 L'oreal, S.A. Use of at least one (dihydro)jasmonic acid derivative as a desquamating agent
DE102005015446A1 (de) * 2005-04-05 2006-10-12 Merck Patent Gmbh Synergisten zur Verstärkung der Wirkung von Repellentien
US9284274B2 (en) 2005-12-07 2016-03-15 Ramot At Tel-Aviv University Ltd. Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
US20090291904A1 (en) * 2005-12-07 2009-11-26 Yoel Kashman Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
FR2909552B1 (fr) 2006-12-12 2009-11-20 Oreal Utilisation cosmetique de l'acide anisique pour favoriser la desquamation
FR2914189A1 (fr) 2007-03-26 2008-10-03 Oreal Utilisation d'une fraction lipopolysaccharidique de vitreoscilla filiformis comme agent stimulant la synthese de peptides antimicrobiens de la peau.
FR2940609B1 (fr) 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique
US9284252B2 (en) 2009-06-09 2016-03-15 Sepal Pharma Ltd. Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
FR2954140A1 (fr) 2009-12-17 2011-06-24 Oreal Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques
FR2956582B1 (fr) 2010-02-19 2012-08-24 Oreal Composition sous forme de poudre comprenant au moins une charge, au moins une huile essentielle et au moins un ester hydroxyle de polyol et d'acide(s) carboxylique(s) en c4 a c16
FR2963233B1 (fr) 2010-07-28 2014-03-14 Oreal Procede pour diminuer les hyperpigmentations post-reactionnelles
FR2968569B1 (fr) 2010-12-13 2013-01-04 Oreal Procede de traitement de la peau grasse non acneique.
FR2972110B1 (fr) 2011-03-01 2013-11-15 Oreal Procede de traitement cosmetique des rougeurs cutanees
JP6356382B2 (ja) 2012-12-21 2018-07-11 ロレアル 化粧品組成物
EP2941238B1 (de) * 2012-12-21 2019-10-16 L'Oréal Kosmetische zusammensetzung
JP6081873B2 (ja) * 2013-06-24 2017-02-15 旭化成ファインケム株式会社 界面活性剤
JP7467421B2 (ja) * 2018-12-19 2024-04-15 フイルメニツヒ ソシエテ アノニム シス－α，β置換シクロペンタノンの製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603146A (en) 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
JPS58180410A (ja) * 1982-04-16 1983-10-21 Shiseido Co Ltd 化粧料
FR2581542B1 (fr) 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
US5091171B2 (en) 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
WO1993010756A1 (en) 1991-11-25 1993-06-10 Richardson-Vicks, Inc. Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
FR2718022B1 (fr) * 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
FR2783517B1 (fr) * 1998-09-22 2001-02-09 Oreal Nouveaux derives de l'acide 10-hyroxy-2-decenoique et utilisation dans une composition destinee a favoriser la desquamation de la peau, et composition le comprenant
JP2001199832A (ja) * 2000-01-13 2001-07-24 Pola Chem Ind Inc 角層の剥離・代謝正常化香料組成物
JP2001207188A (ja) * 2000-01-28 2001-07-31 Pola Chem Ind Inc 過酸化脂質消去用の香料組成物

Also Published As

Publication number Publication date
JP2003238331A (ja) 2003-08-27
FR2835526A1 (fr) 2003-08-08
EP1333022B1 (de) 2011-12-07
EP1333022A3 (de) 2005-12-07
EP1333022A2 (de) 2003-08-06
FR2835526B1 (fr) 2006-02-10
ES2375954T3 (es) 2012-03-07
JP3807735B2 (ja) 2006-08-09

Similar Documents

Publication Publication Date Title
ATE536169T1 (de) Zusammensetzungen enthaltend cyclopentanderivate und deren verwendung zur förderung der abschuppung der haut
DK0773943T3 (da) Forbindelser, der er anvendelige som antiproliferative midler og garft-inhibitorer
MX9102582A (es) Derivados de indol 3,7-disubstituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
AR029634A1 (es) Compuestos derivados heterociclicos utiles como agentes anticancerosos, composicion farmaceutica y procedimiento de tratamiento
FR2662162B1 (fr) Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
DE3761562D1 (de) Taxal-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DK0495982T3 (da) Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel
DE3882614D1 (de) Indol-derivate.
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
BR0307833A (pt) Sìntese controlada de ziprasidona e suas composições
CY1108529T1 (el) Νεα αζαδικυκλικα παραγωγα, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τα περιεχουν
DK391289A (da) Indolderivater
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
HUP0102466A2 (hu) Antiösztrogén hatású új benzo-pirán vagy tiobenzo-pirán származékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények
FR2678930B1 (fr) Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
DE69229339D1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
BRPI0413013A (pt) composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças
DK0861250T3 (da) Amindin- og isothiourinstofderivater som inhibitorer for nitrogenmonoxidsyntase
ATE345787T1 (de) Verwendung von cyclohexenon derivaten zur herstellung eines medikaments für die behandlung von dysurie
NO900636D0 (no) Fremgangsmaate for fremstilling av indolderivater.
IT1266571B1 (it) Derivati della beta-mercapto-propanammide utili nel trattamento delle malattie cardiovascolari
MX9300008A (es) Nucleosidos terapeuticos.
IT1266570B1 (it) Derivati della propanammide n-eteroaril sostituiti utili nel trattamento delle malattie cardiovascolari
BR0012329A (pt) Derivados de benzofurano
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity